Testing effectiveness (Phase 2)Ended earlyNCT04619706
What this trial is testing
Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19
Who this might be right for
COVID-19
Quantum Biopharma 53
Showing 20 of 0 results